Most patients qualify with either: A BMI of 30 or higher, or A BMI of 27+ with a weight-related condition (high blood pressure, type 2 diabetes, high cholesterol) At your consult, Josh reviews your history, medications, and goals to decide whether GLP-1 treatment is clinically appropriate for you
doi:10.1177/0300060520935313 Guo S, Tal R, Jiang H, Yuan T, Liu Y
A second study conducted by the EMA (Association between exposure to GLP-1 receptor agonists and risk of suicide-related and self-injury-related events | HMA-EMA Catalogues of real-world data sources and studies (europa.eu)), based on electronic health records, which examined the risk of suicide-related and self-injury-related events in people with type 2 diabetes mellitus, did not support a causal association between the use of GLP-1 receptor agonists and this risk
Changes that would affect your treatment if you switch: No more citrate: Citrate was found to cause pain when Humira is injected
Population-based age standards for interpreting results on the test of motor infant performance
Best served with extra ice or diluted
